Post by Genmab

166,642 followers

#NewsUpdate: Today, in collaboration with AbbVie, we announced topline results from a Phase 3 study in patients with relapsed/refractory diffuse large B-cell #lymphoma (#DLBCL) for one of our therapies used in a combination regimen. Learn more about the latest news here: http://gmab.ly/ZHsM50Zisi3

Post content

Video Content